Dogelo inu

Our Armacoin GZM coin is specially designed for advertising companies, various media, various greetings registered on the basis of blockchain. Each new message will not be overwritten by the previous one, but will be supplemented. These advertisers can be quite a lot and each of them will receive a payment for their advertising message. The cost of this one message will be 1 GZM. A specific function and variable were added in this coin. The function «Set-Messange» and the global variable «Messange» that is permanently stored in the blockchain. The «SetMessange» function adds a line to the «Messange» function and the 1 GZM is removed from the account of the one who calls this function and transfers this 1 GZM to the advertiser's account. This coin is like a prototype of a Billboard, where the owners of this token, that is, advertisers, can place a message in the contract line for only 1 GZM. The advertiser can place this message on the billboards in different cities, on websites and all visitors will see what is specified in the global parameter of the messange. This coin was created on the ERC-20 contract. The total number of issued and coins for mining does not exceeds 1 billion. The mining of this coin is also unique because it allows to generate GZM tokens with low power renewable energy. This leaves most of the green energy to use for the network, while the miner can use the opportunity to acquire new tokens. We are also developing applications for this smart contract and will give the opportunity to mine these tokens using renewable energy sources, various gadgets with installed pedometers apps, electric vehicles, fitness bracelets and much more. Everything will be done for environmentally friendly and safe mining, as well as for the stimulation of a healthy lifestyle of the people living on our planet. We will encourage everyone who cares about the purity and ecology of our planet.

UNCHAINET connects underutilized server resources with clients who need them. Our blockchain protocols govern the network, align provider incentives with computing resource quality giving choices and transparency to the cloud client market.

The Svandis ecosystem is driven by a community of users and researchers using powerful Svandis tools, analytics, and indicators for professional traders in need of real-time, actionable data and analyses. The Svandis community drives the rapid collection of verifiable data and information through a tokenized incentive system. The platform within the ecosystem provides leading financial research, analytical and visualisation tools for anyone actively involved in the space: short-term and swing traders, traditional holders, analysts, hedge funds, institutional investors, trading firms, and token sale contributors.

Mind AI is an artificial intelligence engine that is capable of human-like abstract reasoning without the need for big data or supercomputers. With its ability to contextualize information and reason, Mind AI is able to generalize knowledge, a feat that no other AI today is capable of. By being able to learn on its own, Mind AI will be able to formulate its own hypotheses and models of how things work, augmenting human intelligence.

Pigzbe uses the blockchain to make money transfers within families borderless, safe, and instant. By unlocking the potential of globalised families as micro-financing networks, Pigzbe teaches children about money in the 21st century.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.